Clinical Trial Update: Safety Study of APD-791 With Aspirin and/or Clopidogrel [Phase 1]

View source ↗

Summary

A Phase 1 safety study of APD-791 in combination with aspirin and/or clopidogrel for acute coronary syndrome has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Drugs mentioned

• APD-791 (APD-791)
• Aspirin (Aspirin)
• CLOPIDOGREL (CLOPIDOGREL)

Snippet

Sponsor: IlDong Pharmaceutical Co Ltd | Conditions: Acute Coronary Syndrome | Phase 1 | Status: TERMINATED